ARRY - Array BioPharma Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue6/30/20186/30/20176/30/20166/30/2015
Total Revenue92,81043,65530,54944,889
Cost of Revenue59,37435,39523,16644,392
Gross Profit33,4368,2607,383497
Operating Expenses
Research Development185,821178,199160,65554,442
Selling General and Administrative58,50039,33636,26731,433
Non Recurring----
Others-80,958-107,197-107,330-7,020
Total Operating Expenses222,737145,733112,758123,247
Operating Income or Loss-129,927-102,078-82,209-78,358
Income from Continuing Operations
Total Other Income/Expenses Net-15,119-14,740-10,63187,727
Earnings Before Interest and Taxes-129,927-102,078-82,209-78,358
Interest Expense-10,814-12,333-10,874-10,247
Income Before Tax-145,046-116,818-92,8409,369
Income Tax Expense2,300---
Minority Interest----
Net Income From Continuing Ops-147,346-116,818-92,8409,369
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-147,346-116,818-92,8409,369
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-147,346-116,818-92,8409,369